FlowMedic is a privately held company, in revenue generating stage.
The company has developed a proprietary technology for miniaturized, low-cost and highly effective compression devices that apply intermittent pressure on the calf muscle and enhance blood circulation.
FlowMedic’s two FDA approved products help solve two major medical needs: post-surgical DVT and Peripheral Arterial Disease (PAD), with a potential market of more than 20 million patients in the US alone.
FlowMedic’s homefit is currently on the market in the US, for post-surgical DVT prevention.
The homefit is the world’s smallest compression device, with published clinical data that shows its ability to enhance blood flow better than most available compression devices (“DVT Pumps”).
Our current focus is home-use post-discharge market, which is an underserved segment that is eligible for insurance reimbursement (private) and a real potential for growth.
The portability of the homefit makes it ideal for this segment and the unique technology combined with our business model, makes the homefit highly attractive for distributors.